help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on January 31, 2003, doi:10.1164/rccm.200207-736BC
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200207-736BCv1
167/11/1478    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lesprit, P.
Right arrow Articles by Carbon, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lesprit, P.
Right arrow Articles by Carbon, C.
American Journal of Respiratory and Critical Care Medicine Vol 167. pp. 1478-1482, (2003)
© 2003 American Thoracic Society


Brief Communication

Role of the Quorum-sensing System in Experimental Pneumonia due to Pseudomonas aeruginosa in Rats

Philippe Lesprit, François Faurisson, Olivier Join-Lambert, Françoise Roudot-Thoraval, Maryline Foglino, Christiane Vissuzaine and Claude Carbon

INSERM EMI-U 9933, and Service d'Anatomie Pathologique, Hôpital Bichat, Paris, France; Département de Santé Publique, Hôpital Henri Mondor, Créteil; and Laboratoire d'Ingénierie des Systèmes Macromoléculaires, Centre National de la Recherche Scientifique, Marseille, France

Correspondence and requests for reprints should be addressed to Dr. Philippe Lesprit, Service d'Immunologie Clinique, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre, 94010 Créteil, France. E-mail: phillipe.lesprit{at}hmn.ap-hop-paris.fr


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The virulence of Pseudomonas aeruginosa is partly controlled by the las quorum-sensing system. A rat model of acute pneumonia was used to investigate the pathophysiological impact of this system by comparing the virulence of the wild-type virulent laboratory strain PAO1 with that of its lasR-deleted mutant PAOR. In comparison with PAO1, PAOR was avirulent after an instillation of 106 cfu (mortality rates, 72 versus 0%, respectively; p < 0.0001). A ten-fold higher inoculum slightly increased the mortality rate induced by PAOR (25%), which remained lower than that induced by PAO1 (75%, p = 0.0001). In addition, with both inocula lung and bronchoalveolar lavage bacterial counts were significantly lower in rats infected with PAOR than with PAO1 (p <= 0.01). Histopathological analysis showed that PAO1 induced a drastic vascular congestion and neutrophil infiltration of the lungs, whereas lung injury in rats infected with PAOR was mild with predominantly macrophage infiltration. This study adds evidence that the quorum-sensing system has an important role in the pathophysiology of P. aeruginosa pulmonary infection.

Key Words: cell-to-cell signaling • experimental pneumonia • Pseudomonas aeruginosa

Pseudomonas aeruginosa is an opportunistic pathogen that is responsible for acute pneumonia in immunocompromised or mechanically ventilated patients and for chronic pulmonary infection in patients with cystic fibrosis. Many P. aeruginosa virulence factors have been shown to be controlled by a complex regulatory circuit involving cell-to-cell signaling (or quorum-sensing, QS) system that allow the bacteria to sense their own cell density and to communicate with each other (1). This results in a coordinated, cell density-dependent production of virulence factors. The main QS systems in gram-negative bacteria are composed of homoserine lactone (HSL)–based autoinducer molecules, which are synthesized by a LuxI-type autoinducer synthase, and a LuxR-type transcriptional activator of target genes (2). Two QS systems have been described in P. aeruginosa. The lasR/lasI system is activated by N-(3-oxododecanoyl)-L-homoserine lactone (3-oxo-C12-HSL) and is required for optimal production of LasA and LasB elastases, alkaline protease, exotoxin A, and proteins of the secretory pathway (3). The second signaling system, referred to as rhl (for rhamnolipid production), is also necessary for optimal production of elastases, protease, pyocyanin, and hemolysin (4). Although both systems are highly specific for their respective autoinducers, there is a QS signaling hierarchy, because the las system activates the expression of rhlR/rhlI. In vitro studies have shown that production of elastase and other virulence factors are reduced in P. aeruginosa mutants defective in the las or the rhl systems (3, 5), but only a few studies have confirmed this role in vivo.

The aim of this study was to determine the role of QS in the physiopathology of acute pulmonary infection by comparing the wild-type laboratory strain P. aeruginosa PAO1, which possesses two functional QS systems, and the lasR-deleted isogenic mutant PAOR. For this purpose, we used a rat model of acute pneumonia derived from Cash and coworkers (6). Strains were compared for their ability to induce death following bacterial challenge at two different inocula, and physiopathological changes were studied by bacterial and semiquantitative histological parameters.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Bacterial Strains
PAO1 is an invasive virulent laboratory strain that possesses two functional QS systems (7). PAOR is a lasR-deleted isogenic mutant produced by gene replacement. Insertional inactivation of lasR, obtained by homologous recombination between a suicide vector and the PAO1 chromosome at the lasR locus, results in a nonfunctional las system that affects the production of elastase and alkaline protease (3, 8).

Preparation of the Inoculum
Bacterial strains were grown overnight in trypticase soy broth at 37°C without shaking, washed, and resuspended in an appropriate volume of phosphate-buffered saline (PBS, pH 7.4) determined by spectrophotometry. An aliquot of this suspension was added to 2% melted agar at 50°C to obtain infected agar beads as described by Cash and coworkers (6), for a final concentration of 107 or 108 cfu/ml. Additional details on the method used are provided in the online supplement.

Infection of Animals
Four-week-old male Sprague-Dawley rats (Charles Rivers, Saint Aubin les Elbeufs, France) were anesthetized by an intraperitoneal injection of ketamine (20 mg/kg of body weight). A cervical incision was performed under ether inhalation for complete analgesia. Then 0.1 ml of the agar bead suspension, containing 106 or 107 cfu, was instilled by the transtracheal route. Control animals were inoculated with uninfected beads prepared by adding sterile PBS to agar. Following inoculation, animals were maintained at 37°C until they were awake and then housed in cages with free access to food and water. A total of 93 rats was used.

Survival
Survival curves were determined after intratracheal inoculation of 106 or 107 cfu of either PAO1 or PAOR.

Bacterial Growth in Lung and Bronchoalveolar Lavage
Rats dying from infection were studied within 12 hours of death, whereas those surviving the bacterial challenge were randomly killed 5 or 10 days after inoculation by an intraperitoneal injection of 2 ml of pentobarbital. The right upper lung was excluded by suture, weighed, and homogenized for bacterial counts. The right lower and the left lungs were then removed en bloc and bronchoalveolar lavage (BAL) was performed by gently flushing 1 ml of sterile PBS into the trachea. Right upper lung homogenates and BAL samples were then sequentially diluted and placed on TS agar plates for assessment of the bacterial counts. The lower limit of detection of culture was 100 cfu/g or ml.

Lung Histopathology
Studies were performed only in rats infected with 107 cfu of PAO1 or PAOR. The left lung was fixed with formalin and embedded in paraffin, and 4-µm-thick lung sections were mounted on slides and stained with hematoxylin–eosin. A semiquantitative analysis using a scoring system of four parameters was made. This included the grading of alveolar necrosis, neutrophil or macrophage infiltration, and vascular congestion. Parameters were semiquantitatively scored from 0 (normal) to 4 by the same investigator, who was unaware of clinical and microbiological data. Each parameter was then classified as minor (score <= 2) or severe (score > 2) for statistical analysis.

Statistical Analysis
Time to death and bacterial counts were expressed as means ± SD. Survival was estimated by the Kaplan–Meier method and survival curves were compared by use of the Mantel–Cox log rank test. Bacterial counts in lung and BAL for different inocula were compared by the Mann–Whitney or Kruskal–Wallis tests. Comparison of histopathological parameters was performed by the Fisher two-tailed exact test. p < 0.05 was considered to be statistically significant. All analyses were performed by means of BMDP statistical software (9).


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Mortality Rates and Mean Time to Death
The mortality rate of animals infected with PAO1 was 72% after the instillation of 106 cfu, whereas all animals infected with PAOR survived bacterial challenge (p < 0.0001) (Figure 1) . Instillation of 107 cfu slightly increased the mortality rate of animals infected with PAOR (25%), which remained lower than that of PAO1 (75%, p = 0.0001). In addition, the mean time to death after infection with PAO1 was significantly shorter than with PAOR (1.69 ± 0.73 versus 2.6 ± 1.2 days, p < 0.01). All control animals survived after injection of uninfected agar beads.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 1. Survival of rats after bacterial challenge. Animals were infected with 106 or 107 cfu of strain PAO1 (squares) or PAOR (circles). Survival curves were compared by use of the Mantel–Cox log rank test. Number of animals in each group: PAO1 106 cfu, n = 22; PAO1 107 cfu, n = 12; PAOR 106 cfu, n = 12; PAOR 107 cfu, n = 36. Mortality was lower after administration of 106 cfu of PAOR, as compared with PAO1 (p < 0.0001). Administration of 107 cfu increased the mortality of PAOR (p = 0.06), but the mortality rate remained lower than that induced by 106 cfu of PAOR (p = 0.001).

 
Bacterial Counts in Lungs and BAL Fluids
Pseudomonas aeruginosa was isolated in pure culture from the lung or BAL samples. When rats were infected with an inoculum of 106 cfu, a 3 log-unit difference was observed between the lungs and BAL of PAO1- and PAOR-infected animals (Table 1) . For the inoculum of 107 cfu, a tenfold rise in bacterial counts was observed in rats infected with PAOR, but bacterial counts remained 100-fold smaller compared with samples isolated from rats infected with the same inoculum of PAO1. Bacterial counts in animals dying after the bacterial challenge were similar between those infected with PAO1 or PAOR (Table 2) . Persistent infection was demonstrated in lung samples and BAL fluids of animals killed 5 or 10 days after inoculation with 107 cfu of PAOR. Among animals killed 5 days after inoculation, BAL bacterial counts were significantly higher in the PAOR group (p = 0.0003 for comparison with the PAO1 group).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Bacterial counts in lungs and bronchoalveolar lavage fluids in rats infected with two different inocula of strains PAO1 and paor

 

View this table:
[in this window]
[in a new window]
 
TABLE 2. Bacterial counts in lungs and bronchoalveolar lavage fluids in rats dying or surviving infection after intratracheal challenge with 107 cfu of strains PAO1 and paor

 
Lung Histopathological Analysis
For both strains, the semiquantitative analysis showed that rats had significant lung injury after bacterial challenge, with numerous foci of necrosis and inflammatory infiltrates, as compared with controls (Figure 2) . Histology of the lungs infected with PAO1 demonstrated severe acute pneumonia with vascular congestion and dense consolidation consisting primarily of neutrophils (p = 0.03 for comparison of congestion with PAOR). In contrast, macrophage infiltration was a predominant finding in the lungs of rats infected with PAOR (p = 0.02 for comparison with PAO1). Inflammatory exudates surrounding beads containing bacteria were found in the adjacent bronchial wall and sometimes obliterated the distal airways. Increased numbers of alveolar macrophages infiltrating the alveolar septa were found in the surrounding parenchyma. Some of the macrophages had ingested bacteria. Macrophage infiltration was absent or moderate in the lungs of rats infected with PAO1 and in the lungs of controls.



View larger version (39K):
[in this window]
[in a new window]
 
Figure 2. Degree of lung injury in rats infected with 107 cfu of strains PAO1 (dark gray columns; n = 12) or PAOR (light gray columns; n = 18). Controls (medium gray columns; n = 5) were inoculated with uninfected beads. Necrosis, amounts of neutrophil (PMN) or macrophage (MN) infiltration, and congestion were scored from 0 (normal) to 4. Data are expressed as the percentage of rats having a score greater than 2 for each parameter. The Fisher exact test (two-tailed) was used for comparison of values for PAO1 and PAOR.

 
Features of chronic pneumonia with predominance of macrophage infiltration were demonstrated in animals surviving inoculation with 107 cfu of PAOR (Figure 3) . This inflammatory response persisted throughout the 10-day period of observation.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 3. Degree of lung injury in rats surviving infection with 107 cfu of strains PAO1 and PAOR. Rats infected with PAO1 (darkest gray bars; n = 3) were killed on Day 5, whereas those infected with PAOR were killed on Day 5 (PAOR surv5, dark gray bars; n = 5) or 10 (PAOR surv10, medium gray bars; n = 8). Controls (light gray bars) were inoculated with uninfected beads. Necrosis, amounts of neutrophil (PMN) or macrophage (MN) infiltration, and congestion were scored from 0 (normal) to 4. Data are expressed as the number of rats having a score greater than 2 for each parameter.

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Pseudomonas aeruginosa is associated with a broad spectrum of lung diseases, ranging from acute pneumonia in immunosuppressed or mechanically ventilated patients to chronic infection in patients with cystic fibrosis. Because the aim of our study was to evaluate the effects of QS expression on the pathophysiology of P. aeruginosa pneumonia, an animal model that closely reproduces the broad spectrum of pulmonary infection in humans was required. Because animal models of acute pneumonia that involve the administration of free P. aeruginosa to rats have shown that the animals either die or clear the inoculum within 48 hours, we used the agarose model described by Cash and coworkers, with several variations (6, 10). In this model, inoculated bacteria are enmeshed in agar beads, allowing the development of a typical bronchopneumonia without the use of any immunosuppressive agent or previous bronchopulmonary injury. Although the model was initially designed to induce a chronic respiratory infection with an inoculum of 104 cfu, dose–response studies performed in our laboratory with the strain PAO1 have demonstrated the influence of the bacterial inoculum on the outcome of lung infection. The mortality rate dramatically increased from 5 to 82% for inocula above a threshold of 106 cfu. Rats infected with inocula of 106 cfu or greater either died of acute pneumonia or survived with a low bacterial clearance within the lungs and pathological features of chronic pneumonia (11). We have previously shown that our experimental model of acute pneumonia is accurate to study the pathogenesis of P. aeruginosa pneumonia and the effect of therapies against this pathogen (10, 11).

In this study, we used the same laboratory strain, PAO1, instead of a clinical isolate, because PAO1 is considered a reference laboratory strain and is characterized as having an invasive phenotype (12). Moreover, several well-defined mutants of PAO1 are available. Although genetic differences between clinical and laboratory strains may exist, studies have shown that clinical and environmental isolates are functionally equivalent in several traits relevant for their virulence properties (13). We first demonstrated that all animals survived after administration of 106 cfu of PAOR, a lasR-deleted isogenic mutant of PAO1. In in vitro studies this mutant demonstrated impaired production of several virulence factors depending on the las QS system. In particular, the elastolytic activity of PAOR is about 5% of that of PAO1 (3). This result is in agreement with previous studies that used different animal models of pulmonary infection with P. aeruginosa QS mutants. In the neonatal mouse model of pneumonia, an inoculum of 5 x 106 cfu of the same PAOR strain resulted in no mortality. In contrast with our study, in which all animals infected with PAOR displayed significant bacterial counts in lungs 5 and 10 days after inoculation, only 48% of mice showed airway colonization 24 hours after infection, suggesting that PAOR was rapidly cleared from the airways in this model (14). In another study, Smith and coworkers compared the ability of lasI- and lasI/rhlI-deleted mutants to colonize the lungs of adult mice. For an inoculum of 106 cfu, bacterial counts were 4 and 3 log units lower in the lungs of mice infected with mutants than with PAO1. However, long-term survival and lung pathophysiological effects of QS-deleted mutants were not assessed in that study, because all animals were studied 24 hours after inoculation (15). Our results demonstrate that the lower mortality observed after PAOR administration cannot be explained by a rapid clearance of bacteria, and the model strongly suggests that the las system play a critical role in the establishment of pneumonia in adult rats.

A tenfold higher inoculum of PAOR (107 cfu) slightly increased the ability of the mutant to induce a lethal pneumonia. The tenfold increase in bacterial counts and histopathological changes confirmed that, under these conditions, PAOR is able to induce significant lung damage. The modest increase in mortality rate (25%) suggests that the virulence of PAOR can be partially restored by increasing the bacterial inoculum despite an inactive las system. Whether the rhl system can operate in the absence of a functional las system is a critical point with regard to the development of antimicrobial agents that interfere with the QS system (16). Indeed, a previous study has shown that production of QS-controlled virulence factors by PAOR can be restored in vitro by starvation (17). When the strain was incubated under these specific culture conditions, upregulation of the rhl QS system was demonstrated. Of note, starvation could not restore the virulence of the lasI/rhlI double mutant. Because we did not incubate PAOR in a specific medium, it is unlikely that nutrient starvation played a role in the restoration of PAOR virulence factors. Increasing bacterial density with an inoculum of 107 cfu may allow the concentration of rhl-ASL molecules to reach a threshold level that is sufficient to activate independently the rhl system. Whether overexpression of the rhl system is sufficient to compensate for the absence of the las system at a high inoculum remains to be investigated in our model by measuring the production of virulence factors and HSL molecules in BAL fluids or lung tissues (18). Of note, when the relative virulence of lasI, rhlI, and lasI/rhlI mutants of PAO1 was compared in the neonatal mouse model of lung infection, the most significant reduction in virulence was seen with the double mutant (19). Our data confirm that therapeutic inhibition of both las and rhl systems will be required for optimal therapeutic efficacy of agents that interfere with the QS system.

Another result of our study is the comparison of lung injury induced by an inoculum of 107 cfu of PAO1 and PAOR. Pulmonary lesions induced by PAO1 were typical of those observed in acute pulmonary infection in humans, with severe necrosis of bronchoalveolar structures, vascular congestion, and neutrophil infiltration. By contrast, two major differences were noted with PAOR. First, a lower bacterial clearance within the airways was noted 5 days after sacrifice of rats infected with PAOR, when BAL results were compared with those of rats infected with PAO1. Second, lung injury in rats surviving infection with PAOR was characterized by the absence of congestion and a predominance of macrophage infiltration, as demonstrated by hematoxylin–eosin staining. The ability of PAOR to colonize the lungs without inducing a significant inflammatory response can be explained by the lack of a functional las system, because it has been shown in vitro that the lasR autoinducer 3-oxo-C12-HSL has immunomodulatory activity (20). In particular, this molecule is a potent inducer of the neutrophil chemokine interleukin-8 and of the inflammatory mediator Cox-2 enzyme, which is involved in the pathophysiological processes of inflammation and edema (20, 21).

In conclusion, our study provides evidence that the las QS system plays an important role in the pathophysiology of P. aeruginosa acute pulmonary infection, as demonstrated by the reduced ability of the mutant to induce mortality, a high lung bacterial load, and lung injury.


    Acknowledgments
 
The authors are grateful to Christian Brun-Buisson, M.D., for reviewing the manuscript and providing comments.


    FOOTNOTES
 
Supported in part by grants from the Association Française de Lutte contre la Mucoviscidose, Paris, France.

This article has an online supplement, which is accessible from this issue's table of contents online at www.atsjournal.org

Received in original form July 23, 2002; accepted in final form January 24, 2003


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Van Delden C, Iglewski BH. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 1998;4:551–560.[Medline]
  2. Fuqua WC, Winans SC, Greenberg EP. Quorum sensing in bacteria: the LuxR–LuxI family of cell density-responsive transcriptional regulators. J Bacteriol 1994;176:269–275.[Free Full Text]
  3. Passador L, Cook JM, Gambello MJ, Rust L, Iglewski BH. Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication. Science 1993;260:1127–1130.[Abstract/Free Full Text]
  4. Latifi A, Winson MK, Foglino M, Bycroft BW, Stewart G, Lazdunski A, Williams P. Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol Microbiol 1995;17:333–343.[CrossRef][Medline]
  5. Pearson JP, Passador L, Iglewski B, Greenberg EP. A second N-acyl-homoserine lactone signal produced by Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1995;92:1490–1494.[Abstract/Free Full Text]
  6. Cash HA, Woods DE, McCullough B, Johanson WG Jr, Bass JA. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis 1979;119:453–459.[Medline]
  7. Kudoh I, Wiener-Kronish JP, Hashimoto S, Pittet JF, Frank D. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol 1994;267:L-551–L-556.
  8. Latifi A, Foglino M, Tanaka K, Williams P, Lazdunski A. A hierarchical quorum sensing cascade in Pseudomonas aeruginosa links the transcriptional activators LasR and RhlR (VsmR) to expression of the stationary-phase {sigma} factor RpoS. Mol Microbiol 1996;21:1137–1146.[CrossRef][Medline]
  9. Dixon WJ, editor. Statistical software BMDP. Berkeley, CA: University of California Press; 1992.
  10. Join-Lambert O, Michea-Hamzehpour M, Kohler T, Chau F, Faurisson F, Dautrey S, Vissuzaine C, Carbon C, Pechere J. Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of P. aeruginosa acute pneumonia in rats. Antimicrob Agents Chemother 2001;45:571–576.[Abstract/Free Full Text]
  11. Join-Lambert O, Faurisson F, Carbon C. Biphasic inoculum-related outcome of lung infection due to Pseudomonas aeruginosa in a rat model of pneumonia [abstract]. In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy Abstract Book; Sept. 24–27, 1998; San Diego. Herndon (VA): American Society for Microbiology; 1998. p. B51.
  12. Sawa T, Ohara M, Kurahashi K, Twining SS, Frank DW, Doroques DB, Long T, Gropper MA, Wiener-Kronish JP. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections. Infect Immun 1998;66:3242–3249.[Abstract/Free Full Text]
  13. Alonso A, Rojo F, Martinez JL. Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ Microbiol 1999;1:421–430.[CrossRef][Medline]
  14. Tang HB, DiMango E, Bryan R, Gambello M, Iglewski BH, Goldberg JB, Prince A. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect Immun 1996;64:37–43.[Abstract]
  15. Smith RS, Harris SG, Phipps R, Iglewski B. The Pseudomonas aeruginosa quorum sensing molecule N-(3-oxododecanoyl) homoserine lactone contributes to virulence and induces inflammation in vivo. J Bacteriol 2002;184:1132–1139.[Abstract/Free Full Text]
  16. Hartman G, Wise R. Quorum sensing: potential means of treating gram-negative infections? Lancet 1998;351:848–849.[CrossRef][Medline]
  17. Van Delden C, Pesci EC, Pearson JP, Iglewski BH. Starvation selection restores elastase and rhamnolipid production in a Pseudomonas aeruginosa quorum-sensing mutant. Infect Immun 1998;66:4478–4502.
  18. Wu H, Song Z, Hentzer M, Andersen JB, Heydorn A, Mathee K, Mo C, Eberl L, Molin S, Hoiby N, Givskov M. Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa. Microbiology 2000;146:2481–2493.[Abstract/Free Full Text]
  19. Pearson JP, Feldman M, Iglewski BH, Prince A. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection. Infect Immun 2000;68:4331–4334.[Abstract/Free Full Text]
  20. Telford G, Wheeler D, Williams P, Tomkins PT, Appleby O, Sewell H, Stewart GS, Bycroft BW, Pritchard DI. The Pseudomonas aeruginosa quorum sensing signal molecule N-(3-oxo-dodecanoyl)-L-homoserine lactone has immunomodulatory activity. Infect Immun 1998;66:36–42.[Abstract/Free Full Text]
  21. DiMango ED, Zar H, Bryan R, Prince AS. Diverse P. aeruginosa gene products stimulate respiratory epithelial cells to express interleukin-8 production. J Clin Invest 1995;96:2204–2210.



This article has been cited by other articles:


Home page
Infect. Immun.Home page
J. F. Teiber, S. Horke, D. C. Haines, P. K. Chowdhary, J. Xiao, G. L. Kramer, R. W. Haley, and D. I. Draganov
Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N-(3-Oxododecanoyl)-L-Homoserine Lactone
Infect. Immun., June 1, 2008; 76(6): 2512 - 2519.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
O. Epaulard, M. Derouazi, C. Margerit, R. Marlu, D. Filopon, B. Polack, and B. Toussaint
Optimization of a Type III Secretion System-Based Pseudomonas aeruginosa Live Vector for Antigen Delivery
Clin. Vaccine Immunol., February 1, 2008; 15(2): 308 - 313.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
M. J. Kazmierczak, M. Wiedmann, and K. J. Boor
Alternative Sigma Factors and Their Roles in Bacterial Virulence
Microbiol. Mol. Biol. Rev., December 1, 2005; 69(4): 527 - 543.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. T. Sadikot, T. S. Blackwell, J. W. Christman, and A. S. Prince
Pathogen-Host Interactions in Pseudomonas aeruginosa Pneumonia
Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1209 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
E. Valade, F. M. Thibault, Y. P. Gauthier, M. Palencia, M. Y. Popoff, and D. R. Vidal
The PmlI-PmlR Quorum-Sensing System in Burkholderia pseudomallei Plays a Key Role in Virulence and Modulates Production of the MprA Protease
J. Bacteriol., April 15, 2004; 186(8): 2288 - 2294.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 288 - 300.
[Full Text] [PDF]


Home page
J. Bacteriol.Home page
S. Cabrol, A. Olliver, G. B. Pier, A. Andremont, and R. Ruimy
Transcription of Quorum-Sensing System Genes in Clinical and Environmental Isolates of Pseudomonas aeruginosa
J. Bacteriol., December 15, 2003; 185(24): 7222 - 7230.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. S. Prince
New Insights from an Old Model
Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1462 - 1463.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200207-736BCv1
167/11/1478    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lesprit, P.
Right arrow Articles by Carbon, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lesprit, P.
Right arrow Articles by Carbon, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society